Sciencast Management’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-11,706
Closed -$790K 377
2022
Q1
$790K Buy
+11,706
New +$680K 0.18% 171
2021
Q3
Sell
-9,100
Closed -$572K 347
2021
Q2
$572K Sell
9,100
-4,973
-35% -$312K 0.12% 248
2021
Q1
$821K Buy
+14,073
New +$761K 0.16% 191
2020
Q3
Sell
-25,901
Closed -$655K 369
2020
Q2
$655K Buy
+25,901
New +$646K 0.16% 208
2020
Q1
Sell
-10,244
Closed -$342K 291
2019
Q4
$342K Buy
10,244
+944
+10% +$29.6K 0.09% 326
2019
Q3
$278K Buy
+9,300
New +$283K 0.09% 296
2018
Q4
Sell
-6,706
Closed -$261K 223
2018
Q3
$261K Buy
+6,706
New +$267K 0.18% 207
2017
Q1
Sell
-7,522
Closed -$249K 333
2016
Q4
$249K Buy
+7,522
New +$292K 0.34% 135

Other funds holding ACHC

Sciencast Management's ACHC Position: Q2 2022 in Review

Sciencast Management sold out of Acadia Healthcare (ACHC) in Q2 2022, closing a stake of 11,706 shares — an estimated $790K sold.

Sciencast Management first reported a position in ACHC in Q4 2016 and held it in 8 quarters. The position peaked at $821K in Q1 2021. 285 funds tracked by Wall St. Rank hold ACHC as of Q2 2022.

  • Sciencast Management reported no remaining Acadia Healthcare position as of Q2 2022 after selling out during the quarter.
  • Sciencast Management sold 11,706 Acadia Healthcare shares in Q2 2022, an estimated $790K.
  • Sciencast Management first reported a position in Acadia Healthcare in Q4 2016 and held it in 8 quarters.
  • Sciencast Management's Acadia Healthcare position peaked at $821K in Q1 2021.
  • 285 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2022.

Based on Sciencast Management's 13F filing for Q2 2022, filed 3 Aug 2022.